Iovance Biotherapeutics's Options: A Look at What the Big Money Is Thinking
Iovance Biotherapeutics's Options: A Look at What the Big Money Is Thinking
Whales with a lot of money to spend have taken a noticeably bearish stance on Iovance Biotherapeutics.
有很多钱可以花的鲸鱼对Iovance Biotherapeutics采取了明显的看跌立场。
Looking at options history for Iovance Biotherapeutics (NASDAQ:IOVA) we detected 17 trades.
从Iovance Biotherapeutics（纳斯达克股票代码：IOVA）的期权历史来看，我们发现了17笔交易。
If we consider the specifics of each trade, it is accurate to state that 17% of the investors opened trades with bullish expectations and 82% with bearish.
如果我们考虑每笔交易的具体情况，可以准确地说，有17％的投资者以看涨的预期开盘，82％的投资者以看跌的预期开盘。
From the overall spotted trades, 12 are puts, for a total amount of $589,675 and 5, calls, for a total amount of $608,250.
在所有已发现的交易中，有12笔是看跌期权，总额为589,675美元，5笔看涨期权，总额为608,250美元。
Projected Price Targets
预计价格目标
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $10.0 and $15.0 for Iovance Biotherapeutics, spanning the last three months.
在评估了交易量和未平仓合约之后，很明显，主要市场走势者将注意力集中在Iovance Biotherapeutics在过去三个月的10.0美元至15.0美元之间的价格区间上。
Insights into Volume & Open Interest
对交易量和未平仓合约的见解
In today's trading context, the average open interest for options of Iovance Biotherapeutics stands at 1138.5, with a total volume reaching 11,833.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Iovance Biotherapeutics, situated within the strike price corridor from $10.0 to $15.0, throughout the last 30 days.
在当今的交易背景下，Iovance Biotherapeutics期权的平均未平仓合约为1138.5张，总成交量达到11,833.00。随附的图表描绘了过去30天中Iovance Biotherapeutics高价值交易的看涨和看跌期权交易量以及未平仓合约的变化，这些交易位于行使价走廊内，从10.0美元到15.0美元。
Iovance Biotherapeutics Option Volume And Open Interest Over Last 30 Days
Iovance Biotherapeutics 过去 30 天的期权交易量和未平仓合约
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA | CALL | SWEEP | BEARISH | 12/20/24 | $2.55 | $2.45 | $2.45 | $14.00 | $220.5K | 8 | 602 |
| IOVA | CALL | TRADE | BEARISH | 12/20/24 | $2.55 | $2.4 | $2.4 | $14.00 | $144.0K | 8 | 602 |
| IOVA | CALL | SWEEP | BULLISH | 06/21/24 | $2.5 | $2.3 | $2.5 | $10.00 | $125.0K | 3.0K | 20 |
| IOVA | PUT | SWEEP | BULLISH | 09/20/24 | $4.2 | $4.0 | $4.0 | $15.00 | $78.8K | 578 | 197 |
| IOVA | PUT | SWEEP | BEARISH | 09/20/24 | $1.55 | $1.4 | $1.55 | $10.00 | $74.7K | 854 | 231 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA | 打电话 | 扫 | 粗鲁的 | 12/20/24 | 2.55 美元 | 2.45 美元 | 2.45 美元 | 14.00 美元 | 220.5 万美元 | 8 | 602 |
| IOVA | 打电话 | 贸易 | 粗鲁的 | 12/20/24 | 2.55 美元 | 2.4 美元 | 2.4 美元 | 14.00 美元 | 144.0 万美元 | 8 | 602 |
| IOVA | 打电话 | 扫 | 看涨 | 06/21/24 | 2.5 美元 | 2.3 美元 | 2.5 美元 | 10.00 美元 | 125.0K | 3.0K | 20 |
| IOVA | 放 | 扫 | 看涨 | 09/20/24 | 4.2 美元 | 4.0 美元 | 4.0 美元 | 15.00 美元 | 78.8 万美元 | 578 | 197 |
| IOVA | 放 | 扫 | 粗鲁的 | 09/20/24 | 1.55 美元 | 1.4 美元 | 1.55 美元 | 10.00 美元 | 74.7 万美元 | 854 | 231 |
About Iovance Biotherapeutics
关于 Iovance 生物疗法
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Iovance Biotherapeutics Inc是一家处于临床阶段的生物制药公司，通过利用人体免疫系统识别和摧毁各种癌细胞的能力，使用针对每位患者的个性化疗法，开创了一种治疗癌症的变革性方法。该公司正在为第一种治疗实体瘤的自体T细胞疗法可能获得美国监管部门的批准和商业化做准备。其目标是成为创新、开发和提供针对实体瘤癌患者的肿瘤浸润淋巴细胞（TIL）疗法的领导者。
In light of the recent options history for Iovance Biotherapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鉴于Iovance Biotherapeutics最近的期权历史，现在应该将重点放在公司本身上。我们的目标是探索其目前的表现。
Where Is Iovance Biotherapeutics Standing Right Now?
Iovance Biotherapeutics 现在处于什么位置？
- Currently trading with a volume of 11,609,305, the IOVA's price is down by -17.77%, now at $11.06.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 88 days.
- IOVA目前的交易量为11,609,305美元，其价格下跌了-17.77％，目前为11.06美元。
- RSI读数表明，该股目前可能已接近超卖。
- 预计收益将在88天后发布。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Iovance Biotherapeutics with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用Benzinga Pro了解Iovance Biotherapeutics的最新期权交易，以获取实时警报。